Team

Physician Team

The physician team at our treatment center is composed of highly skilled and experienced medical professionals dedicated to providing comprehensive care for patients undergoing advanced therapies, including regenerative stem cell treatments. Our multidisciplinary team includes board-certified specialists in regenerative medicine, orthopedics, neurology, cardiology, and internal medicine, ensuring a holistic approach to patient care. Each physician brings a wealth of expertise in their respective fields, working collaboratively to develop personalized treatment plans that prioritize patient safety, efficacy, and comfort. The team stays at the forefront of medical advancements through continuous education and research, applying the latest techniques and technologies to deliver cutting-edge therapeutic solutions. Their commitment to excellence, combined with compassionate care, ensures that every patient receives the highest standard of medical treatment throughout their healing journey.

Elliot Lander M.D. F.A.C.S

Dr. Elliot Lander, a Board-Certified Urologist, is Co-Founder and Co-Medical Director of California Stem Cell Treatment Center, Cell Surgical Network. Elliot B. Lander, M.D. F.A.C.S. is a Board-Certified Surgeon. He was born in Los Angeles, California. He graduated Magna Cum Laude and Phi Beta Kappa from Occidental College with Distinction in Biochemistry.
He attended medical school at the University of California, Irvine. For six years after medical school, Dr. Lander studied General Surgery and then Urologic Surgery at the University of California, Irvine. He was a Clinical Assistant Professor of Urology at UC Irvine while in practice in Orange County for five years. During that time he was active in teaching residents and doing research. Dr. Lander has been elected as a Fellow of the American College of Surgeons. He has served as Chief of Urology at Eisenhower Medical Center and Chief of Surgery at John F. Kennedy Hospital. Dr. Lander has been on staff at Eisenhower Medical Center for over twenty years. Dr. Lander is founder of Nanologix Research Inc., a company dedicated to a novel drug therapy for interstitial cystitis. Dr. Lander is a pioneer in regenerative urology with publications on using stem cells to treat Peyronies Disease and Erectile Dysfunction, as well as interstitial cystitis. Dr. Lander is currently involved in IRB approved translational stem cell treatment research at the California Stem Cell Treatment Center. He is a founding member of the International Cell Surgical Society ICSS, a nonprofit organization supporting cell therapy research and education. ICSS supports Regenatrak™ which is an online regenerative medicine database tool use by clinicians to track clinical outcomes and adverse events from all over the globe. Dr. Lander with Dr. Berman and their team of multi-specialty experts were instrumental in bringing fat derived stem cell technology to the United States in 2010 and have pioneered several new techniques in regenerative medicine. Dr. Lander is co-founder of Cell Surgical Network, an international research network dedicated to studying the clinical applications of adipose-derived stem cells. Research affiliate physicians trained by the Cell Surgical Network team can be found all around the world. Dr. Lander is co-author of The Stem Cell Revolution, a popular book on regenerative medicine.

Thomas J. Grogan, MD

Dr. Grogan is a practicing pediatric orthopedic surgeon at Pacific Coast Sports Medicine in Los Angeles. Dr. Grogan graduated cum laude from Princeton University with a degree in Biology and received his medical degree from the University of Cincinnati College of Medicine.
Dr. Grogan’s orthopedic training has included an orthopedic residency at UCLA plus several orthopedic fellowships in pediatric orthopedics, trauma, and NIH sponsored joint replacement surgery. Following his orthopedic training he returned to Los Angeles, spending six years at Shriner’s Hospital for Crippled Children, including serving as Assistant Chief in 1996 and 1997. In addition to his clinical practice, he spent several years involved in managed care consulting as an orthopedic surgeon and has developed special expertise in this area. He has collaborated with the American Academy of Orthopedic Surgeons in the development of a handbook and audiotape entitled, “Health Care Reform and Managed Care: A Guidebook for Orthopedic Surgeons”. In addition, he has served as the lead faculty member for the AAOS for their 1995, 12 city educational seminar, “Taking Charge: Managed Care Contracting for Orthopedic Surgeons” and as a faculty member for the AAOS’s 1996 seminar series entitled, “Winning at Risk: The Interplay of Cost, Quality, and Access in Orthopedic Practice”. He most recently served as a faculty member for the AAOS’s 2009, 2010, 2011 and 2012 seminars, “Practice Management Symposium for Practicing Orthopedic Surgeons’. He is currently chairman of the Practice Management Committee for the American Academy of Orthopedic Surgeons and a member of their Council on Education. He is a member of Alpha Omega Alpha, Honor Medical Society, the Sigma XI Scientific Research Society, California Orthopedic Association (COA), the Pediatric Orthopedic Society of North America (POSNA), the American Academy of Orthopedic Surgeons (AAOS), and is a diplomate of the American Board of Orthopedic Surgery.

In Memoriam, Mark Berman, MD, FACS

Mark Berman, MD, is an internationally renowned expert in the field of regenerative medicine and cellular therapy and helped to restore the health of thousands of patients around the globe – without dangerous prescription drugs or risky surgery.  Together with partner Elliot Lander MD, he co-founded the CSN, a global network of 500+ doctors worldwide dedicated to the research and advancement of cellular therapy.

For over a decade, Dr. Berman has tracked and followed his patient’s stem cell treatment outcomes, using IRB approved cellular therapy protocols, in an independent, 3rd party, global medical database. His patients are routinely followed up with for a 5 year period to track safety and conditions specific outcomes, data which has been used to drive informed clinical decisions, but also has been used for over 10 peer-reviewed publications. Since 2010, Dr. Berman, along with his multi-disciplinary team of physicians, is proud to have helped restore the health of thousands of patients with a wide array of medical  ailments and diseases, including various types of orthopedic conditions/injuries, auto-immune disorders, cardiac/pulmonary disease, neurological disorders, chronic pain, and much more. While he has cared for numerous high profile personalities, celebrities, and professional athletes, he has also donated his time to help those unprivileged and in need. Currently, he is  one of few physicians in the United States qualified to freeze and store his patient’s stem cells.
Dr. Berman is devoted to furthering the field of regenerative medicine and has published numerous scientific papers – including a first of its kind study that demonstrated the safety and efficacy of autologous stem cell therapy.  Through his advanced training and decades of continuing education, he is able to provide his patients with the latest advancements in stem cell therapy and the field of regenerative medicine.  Above all, he is committed to providing his patients with only the most safe, effective, and ethical cell-based therapies available, all revolving around their own personal cells. As co-founder and co-medical director of the California Stem Cell Treatment Center, Dr. Berman’s philosophy is to provide the highest quality, state of the art care while maintaining concern and compassion for each patient’s individual needs. This means treating the whole person, not just their injury or illness. 

In his spare time, Dr. Berman enjoys many different sporting activities, plays the guitar, and loves to read and write.  In fact, he’s authored numerous scientific papers in the field of regenerative medicine and co-author of the book, The Stem Cell Revolution, which highlights real stories from a number of their patients that were given their health back with stem cell treatment.